Where Genome Meets Phenome: Rationale for Integrating Genetic and Protein Biomarkers in the Diagnosis and Management of Dilated Cardiomyopathy and Heart Failure

Burkett, 2005, Clinical and genetic issues in familial dilated cardiomyopathy, J Am Coll Cardiol, 45, 969, 10.1016/j.jacc.2004.11.066

Houle, 2010, Phenomics: the next challenge, Nat Rev Genet, 11, 855, 10.1038/nrg2897

Chen, 2008, Variations in DNA elucidate molecular networks that cause disease, Nature, 452, 429, 10.1038/nature06757

Adams, 2010, Systems biology and heart failure: concepts, methods, and potential research applications, Heart Fail Rev, 15, 371, 10.1007/s10741-009-9138-x

Whitelaw, 2001, Retrotransposons as epigenetic mediators of phenotypic variation in mammals, Nat Genet, 27, 361, 10.1038/86850

Gluckman, 2008, Effect of in utero and early-life conditions on adult health and disease, N Engl J Med, 359, 61, 10.1056/NEJMra0708473

Guttmacher, 2004, The family history—more important than ever, N Engl J Med, 351, 2333, 10.1056/NEJMsb042979

Hershberger, 2009, Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline, J Card Fail, 15, 83, 10.1016/j.cardfail.2009.01.006

Hershberger, 2010, Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals, Genet Med, 12, 655, 10.1097/GIM.0b013e3181f2481f

Kushner, 2006, Clinical characteristics of 304 kindreds evaluated for familial dilated cardiomyopathy, J Cardiac Failure, 12, 422, 10.1016/j.cardfail.2006.03.009

Michels, 1992, The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy, N Engl J Med, 326, 77, 10.1056/NEJM199201093260201

Hershberger, 2011, State of the Art Review, J Am Coll Cardiol, 57, 1641, 10.1016/j.jacc.2011.01.015

Kelly, 2009, Multiple mutations in genetic cardiovascular disease: a marker of disease severity?, Circ Cardiovasc Genet, 2, 182, 10.1161/CIRCGENETICS.108.836478

Bagnall, 2011, Molecular diagnostics of cardiomyopathies: the future is here, Circ Cardiovasc Genet, 4, 103, 10.1161/CIRCGENETICS.110.959247

Dellefave, 2010, The genetics of dilated cardiomyopathy, Curr Opin Cardiol, 25, 198, 10.1097/HCO.0b013e328337ba52

Hershberger, 2009, Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circ Heart Fail, 2, 253, 10.1161/CIRCHEARTFAILURE.108.817346

Jefferies, 2010, Dilated cardiomyopathy, Lancet, 375, 752, 10.1016/S0140-6736(09)62023-7

Herman, 2012, Truncations of titin causing dilated cardiomyopathy, N Engl J Med, 366, 619, 10.1056/NEJMoa1110186

Norton, 2012, Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era, Circ Cardiovasc Genet, 5, 167, 10.1161/CIRCGENETICS.111.961805

Hershberger, 2008, Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy, Clin Translational Science, 1, 21, 10.1111/j.1752-8062.2008.00017.x

Hershberger, 2010, Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy, Circ Cardiovasc Genet, 3, 155, 10.1161/CIRCGENETICS.109.912345

Hershberger, 2010, A glimpse into multigene rare variant genetics: triple mutations in hypertrophic cardiomyopathy, J Am Coll Cardiol, 55, 1454, 10.1016/j.jacc.2009.12.025

Bodmer, 2008, Common and rare variants in multifactorial susceptibility to common diseases, Nat Genet, 40, 695, 10.1038/ng.f.136

Villard, 2011, A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy, Eur Heart J, 32, 1065, 10.1093/eurheartj/ehr105

Norton, 2011, Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy, Am J Hum Genet, 88, 273, 10.1016/j.ajhg.2011.01.016

Rampersaud, 2010, Common susceptibility variants examined for association with dilated cardiomyopathy, Ann Hum Genet, 74, 110, 10.1111/j.1469-1809.2010.00566.x

Horne, 2011, Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy, Circ Cardiovasc Genet, 4, 359, 10.1161/CIRCGENETICS.110.959205

Cappola, 2010, Common variants in HSPB7 and FRMD4B associated with advanced heart failure, Circ Cardiovasc Genet, 3, 147, 10.1161/CIRCGENETICS.109.898395

Schonberger, 2005, Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss, Nat Genet, 37, 418, 10.1038/ng1527

Gupta, 2010, Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption, Basic Res Cardiol, 105, 365, 10.1007/s00395-010-0085-4

Felker, 2000, Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy, N Engl J Med, 342, 1077, 10.1056/NEJM200004133421502

Maekawa, 2007, Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity, Circulation, 115, 5, 10.1161/CIRCULATIONAHA.106.670554

Xiong, 2002, Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease, Nat Med, 8, 872, 10.1038/nm737

Noutsias, 2001, Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections, Circulation, 104, 275, 10.1161/01.CIR.104.3.275

Cooper, 2010, Genomic and proteomic analysis of myocarditis and dilated cardiomyopathy, Heart Fail Clin, 6, 75, 10.1016/j.hfc.2009.08.012

Gramolini, 2008, Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses, Mol Cell Proteomics, 7, 519, 10.1074/mcp.M700245-MCP200

Heidecker, 2008, Transcriptomic biomarkers for individual risk assessment in new-onset heart failure, Circulation, 118, 238, 10.1161/CIRCULATIONAHA.107.756544

Alexander, 2011, Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy, Eur J Clin Invest, 41, 527, 10.1111/j.1365-2362.2010.02441.x

Hanash, 2003, Disease proteomics, Nature, 422, 226, 10.1038/nature01514

Granger, 2004, National Heart, Lung, and Blood Institute Clinical Proteomics Working Group report, Circulation, 109, 1697, 10.1161/01.CIR.0000121563.47232.2A

Daniels, 2007, Natriuretic peptides, J Am Coll Cardiol, 50, 2357, 10.1016/j.jacc.2007.09.021

Maisel, 2002, Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233

Mueller, 2004, Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea, N Engl J Med, 350, 647, 10.1056/NEJMoa031681

Moe, 2007, N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study, Circulation, 115, 3103, 10.1161/CIRCULATIONAHA.106.666255

Felker, 2009, Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials, Am Heart J, 158, 422, 10.1016/j.ahj.2009.06.018

Weinberg, 2003, Identification of serum soluble ST2 receptor as a novel heart failure biomarker, Circulation, 107, 721, 10.1161/01.CIR.0000047274.66749.FE

Januzzi, 2007, Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study, J Am Coll Cardiol, 50, 607, 10.1016/j.jacc.2007.05.014

Manzano-Fernandez, 2011, Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction, Am J Cardiol, 107, 259, 10.1016/j.amjcard.2010.09.011

La Vecchia, 2000, Cardiac troponin I as diagnostic and prognostic marker in severe heart failure, J Heart Lung Transplant, 19, 644, 10.1016/S1053-2498(00)00120-0

Hudson, 2004, Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis, Am Heart J, 147, 546, 10.1016/j.ahj.2003.10.014

Latini, 2007, Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure, Circulation, 116, 1242, 10.1161/CIRCULATIONAHA.106.655076

deFilippi, 2010, Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults, JAMA, 304, 2494, 10.1001/jama.2010.1708

Cicoira, 2004, Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure, J Card Fail, 10, 403, 10.1016/j.cardfail.2004.01.010

Querejeta, 2000, Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease, Circulation, 101, 1729, 10.1161/01.CIR.101.14.1729

Yan, 2006, Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure, J Card Fail, 12, 514, 10.1016/j.cardfail.2006.05.012

van Kimmenade, 2006, Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure, J Am Coll Cardiol, 48, 1217, 10.1016/j.jacc.2006.03.061

Kapur, 2010, Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure, Am J Cardiol, 106, 1770, 10.1016/j.amjcard.2010.08.018

Yndestad, 2009, Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure, Eur Heart J, 30, 1229, 10.1093/eurheartj/ehp088

Aghel, 2010, Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure, J Card Fail, 16, 49, 10.1016/j.cardfail.2009.07.003

Staudt, 2007, Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy, J Am Coll Cardiol, 49, 1684, 10.1016/j.jacc.2006.11.051

Kuner, 2008, Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies, Physiol Genomics, 34, 88, 10.1152/physiolgenomics.00299.2007